UA50753C2 - Translated By PlajКОМПЛЕКСЫ КАСКАДНЫХ ПОЛИМЕРОВ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКОЕ СРЕДСТВО - Google Patents

Translated By PlajКОМПЛЕКСЫ КАСКАДНЫХ ПОЛИМЕРОВ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКОЕ СРЕДСТВО

Info

Publication number
UA50753C2
UA50753C2 UA98073923A UA98073923A UA50753C2 UA 50753 C2 UA50753 C2 UA 50753C2 UA 98073923 A UA98073923 A UA 98073923A UA 98073923 A UA98073923 A UA 98073923A UA 50753 C2 UA50753 C2 UA 50753C2
Authority
UA
Ukraine
Prior art keywords
cascade
reproduction
independently represent
multiplicity
polymer complexes
Prior art date
Application number
UA98073923A
Other languages
English (en)
Ukrainian (uk)
Inventor
Херіберт Шмітт-Вілліх
Хериберт Шмитт-Виллих
Йоханнесс Платцек
Бернд РАДЮХЕЛЬ
Ханнс-Йоахім Вайнманн
Ханнс-Иоахим Вайнманн
Вольфганг ЕБЕРТ
Бернд Міссельвітц
Бернд МИССЕЛЬВИТЦ
Андреас Мюлєр
Томас Френцель
Original Assignee
Шерінг Акцієнгезелльшафт
Шеринг Акциенгезелльшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шерінг Акцієнгезелльшафт, Шеринг Акциенгезелльшафт filed Critical Шерінг Акцієнгезелльшафт
Publication of UA50753C2 publication Critical patent/UA50753C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/12Macromolecular compounds
    • A61K49/124Macromolecular compounds dendrimers, dendrons, hyperbranched compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Комплексы каскадных полимеров, содержащие а) комплексообразующие лиганды общей формулы (I), где А означает азотсодержащее каскадное ядро базисной мультиплетности a, X и Y, независимо друг от друга, простую связь или каскадное репродуктивное мономерное звено репродуктивной мультиплетности х или у, Z и W, независимо друг от друга, означают каскадное репродуктивное мономерное звено репродуктивной мультиплетности z или w, К означает остаток комплексообразователя, а означает числа от 2 до 12, х, у, z и w, независимо друг от друга, означают числа 1-4, при условии, что, по меньшей мере, два репродуктивных мономерных звена различны, что для произведения мультиплетностей действительно и что, по меньшей мере, одно из каскадных репродуктивных мономерных звеньев X, Y, Z, W означает репродуктивное мономерное звено 1,4,7,10-тетраазациклододекана или 1,4,8,11-тетраазациклотетрадекана, б) по меньшей мере, 16 ионов элемента порядковых номеров 20-29, 39, 42, 44 или 57-83, в) при необходимости, катионы неорганических и/или органических оснований, аминокислот или амидов аминокислот, а также г) при необходимости, ацилированные концевые аминогруппы, являющиеся ценными соединениями для диагностики и терапии.
UA98073923A 1995-12-22 1996-11-29 Translated By PlajКОМПЛЕКСЫ КАСКАДНЫХ ПОЛИМЕРОВ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКОЕ СРЕДСТВО UA50753C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19549286A DE19549286A1 (de) 1995-12-22 1995-12-22 Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
PCT/EP1996/005315 WO1997023245A1 (de) 1995-12-22 1996-11-29 Kaskaden-polymer-komplexe, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel

Publications (1)

Publication Number Publication Date
UA50753C2 true UA50753C2 (ru) 2002-11-15

Family

ID=7781739

Family Applications (1)

Application Number Title Priority Date Filing Date
UA98073923A UA50753C2 (ru) 1995-12-22 1996-11-29 Translated By PlajКОМПЛЕКСЫ КАСКАДНЫХ ПОЛИМЕРОВ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКОЕ СРЕДСТВО

Country Status (23)

Country Link
US (1) US6057419A (ru)
EP (1) EP0868202B1 (ru)
JP (1) JP4031041B2 (ru)
KR (1) KR100461476B1 (ru)
AT (1) ATE222776T1 (ru)
BG (1) BG63105B1 (ru)
CA (1) CA2241187A1 (ru)
CZ (1) CZ294238B6 (ru)
DE (2) DE19549286A1 (ru)
DK (1) DK0868202T3 (ru)
ES (1) ES2181924T3 (ru)
IL (1) IL124677A (ru)
MX (1) MX9804860A (ru)
NO (1) NO314545B1 (ru)
NZ (1) NZ323397A (ru)
PL (1) PL187835B1 (ru)
PT (1) PT868202E (ru)
RU (1) RU2197495C2 (ru)
SK (1) SK283334B6 (ru)
TW (1) TW520377B (ru)
UA (1) UA50753C2 (ru)
WO (1) WO1997023245A1 (ru)
ZA (1) ZA9610822B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19652387A1 (de) * 1996-12-04 1998-06-10 Schering Ag Macrocyclische Metallkomplexcarbonsäuren, ihre Verwendung sowie Verfahren zu ihrer Herstellung
DE19728954C1 (de) * 1997-06-30 1999-04-22 Schering Ag Saccharid-Konjugate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19744003B4 (de) * 1997-09-26 2004-07-08 Schering Ag Kontrastmittel für das Infarkt- und Nekroseimaging
DE19758105A1 (de) * 1997-12-18 1999-06-24 Schering Ag Dendritische Polymer-Saccharid-Konjugate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung
US7405320B2 (en) * 1998-06-22 2008-07-29 Immunomedics, Inc. Therapeutic and diagnostic conjugates for use with multispecific antibodies
FR2841258A1 (fr) * 2002-06-20 2003-12-26 Pf Medicament Procede et preparation de mononegavirus recombinants et leurs applications
CN101400661A (zh) * 2006-03-14 2009-04-01 马林克罗特公司 四氮杂大环衍生物的金属络合物
DE102007002726A1 (de) * 2007-01-18 2008-07-31 Bayer Schering Pharma Aktiengesellschaft Neue Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
WO2014197763A1 (en) * 2013-06-07 2014-12-11 The Board Of Regents Of The University Of Teas System Molecular design toward dual-modality probes for radioisotope-based imaging (pet or spect) and mri
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
WO2018096082A1 (en) 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
MX2021006024A (es) 2018-11-23 2021-07-06 Bayer Ag Formulacion de medios de contraste y proceso para prepararlos.
RU2706705C1 (ru) * 2019-03-28 2019-11-20 Федеральное государственное бюджетное учреждение науки Иркутский институт химии им.А.Е.Фаворского Сибирского отделения Российской академии наук Водорастворимые магнитоактивные нанобиокомпозиты флавоноидных комплексов гадолиния на основе природного конъюгата арабиногалактана с биофлавоноидами и способ получения этих нанобиокомпозитов

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527524A (en) * 1986-08-18 1996-06-18 The Dow Chemical Company Dense star polymer conjugates
DE3938992A1 (de) * 1989-11-21 1991-05-23 Schering Ag Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE4344460A1 (de) * 1993-12-22 1995-06-29 Schering Ag Metallkomplexe von dendrimeren Makromolekülen, diese enthaltende diagnostische Mittel sowie Verfahren zur Herstellung der Komplexe und Mittel
GB9404208D0 (en) * 1994-03-04 1994-04-20 Nycomed Salutar Inc Chelants
GB9407812D0 (en) * 1994-04-20 1994-06-15 Nycomed Salutar Inc Compounds
DE4425857A1 (de) * 1994-07-07 1996-01-11 Schering Ag Kaskaden-Polymer-Komplexe, Verfahren zur ihrer Herstellung und diese enthaltende pharmazeutische Mittel
US5919433A (en) * 1996-12-04 1999-07-06 Schering Aktiengesellschaft Macrocyclic metal complex carboxylic acids, their use as well as process for their production

Also Published As

Publication number Publication date
NO314545B1 (no) 2003-04-07
KR100461476B1 (ko) 2005-04-06
ES2181924T3 (es) 2003-03-01
PL327977A1 (en) 1999-01-04
RU2197495C2 (ru) 2003-01-27
ATE222776T1 (de) 2002-09-15
NZ323397A (en) 1999-11-29
BG63105B1 (bg) 2001-04-30
CA2241187A1 (en) 1997-07-03
IL124677A0 (en) 1998-12-06
DE59609603D1 (de) 2002-10-02
SK283334B6 (sk) 2003-06-03
JP2000510880A (ja) 2000-08-22
DK0868202T3 (da) 2002-12-09
MX9804860A (es) 1998-10-31
SK85498A3 (en) 1998-11-04
PL187835B1 (pl) 2004-10-29
CZ198198A3 (cs) 1998-09-16
DE19549286A1 (de) 1997-06-26
NO982903L (no) 1998-06-22
PT868202E (pt) 2003-01-31
WO1997023245A1 (de) 1997-07-03
ZA9610822B (en) 1997-06-27
CZ294238B6 (cs) 2004-11-10
EP0868202B1 (de) 2002-08-28
IL124677A (en) 2005-03-20
NO982903D0 (no) 1998-06-22
BG102565A (en) 1999-06-30
KR19990076638A (ko) 1999-10-15
EP0868202A1 (de) 1998-10-07
US6057419A (en) 2000-05-02
JP4031041B2 (ja) 2008-01-09
TW520377B (en) 2003-02-11

Similar Documents

Publication Publication Date Title
NZ312127A (en) Cascade polymer complexes, method of manufacture and use for the diagnosis of tumors
IL114405A0 (en) Cascade polymer complexes pharmaceutical compositions containing the same and processes for the preparation thereof
UA50753C2 (ru) Translated By PlajКОМПЛЕКСЫ КАСКАДНЫХ ПОЛИМЕРОВ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКОЕ СРЕДСТВО
GR3031629T3 (en) Complexe builders bonded to sterwise prepared polymers, their complexes and conjugates, process for their preparation and pharmaceutical agents containing the same.
GR3017586T3 (en) Complex porphyrine compounds substituted in position 13,17 by propionic acid and propionic-acid derivatives, process for their preparation and pharmaceutical compositions containing same.
CA2277877A1 (en) Nitric oxide synthase inhibitors
MX9604020A (es) Arilalquildiazinonas.
CA2123048A1 (en) Tetrazole derivatives of bile acids, processes for their preparation and the use of these compounds as medicaments
CA2019404A1 (en) 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
ZA961395B (en) Metal complexes suitable for use in diagnosis and therapy
GEP20032929B (en) 6-O-Methyl-Erythromycin A Class, Novel 8a-and 9a-15-Membered Lactams, Method for Their Production and Pharmaceutical Composition for Treatment of Bacterial Infections
MY122576A (en) Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
CA2176603A1 (en) Novel palladium complexes and methods for using same in the treatment of tumors and psoriasis
ATE357243T1 (de) Stoffe und zusammensetzungen für die verabreichung aktiver substanzen